Chr. Hansen in a nutshell:
• leading global biotechnology company
• key business: Development and manufacturing of
enzymes, food cultures and probiotic bacterial
strains for food, pharma and agricultural industry
as well as functional food ingredients for baby
food
• listed in C20-Index at NASDAQ OMX Copenhagen
• global turnover: 1,077 billion Euro in fiscal year
2020/21
• more than 3,700 employees in more than
30 countries worldwide
• more than 30 subsidiaries worldwide
• research facilities in Denmark and USA
• development centers in Denmark, USA, France
and Germany
• application centers in more than 20 countries
• modern production facilities on three continents
• awarded on the world’s most sustainable company
in January 2019
• ranking to the second most sustainable company
in the world in 2020 and 2022
• entered the market of human milk oligosaccharides
in September 2020
Chr. Hansen GmbH
Große Drakenburger Straße 93-97
31582 Nienburg, Germany
Phone: +49 (0) 5021 9630
service@chr-hansen.com, www.chr-hansen.com
9
this enzyme to the cheese industry worldwide, from Nienburg via
a branch network of the group. The research department, which
was set up on site, in the meantime worked on continuous further
development of the production process and the environmental
friendliness of processes. The course is set: Chr. Hansen focuses
on novel agricultural solutions, reduction of food waste as well as
improved health care. The factory, which by then also comprised a
distribution and service center, today employs 156 people.
HMO production site in Rheinbreitbach
and R&D center in Bonn
In September 2020 Chr. Hansen entered the growth market of
human milk oligosaccharides. At the HMO production facility in
Rheinbreitbach and the R&D center in Bonn, the competencies of
more than 100 scientists, production specialists and employees
are focused on continuously developing new HMO production processes
and running industrial scale production, while maintaining
the highest quality standards for ingredients in baby food.
Human milk oligosaccharides (HMOs) are complex milk sugars that
are found in high amounts only in breast milk. HMOs are the third
most abundant solid component of breast milk, surpassed only by
lipids and lactose. Scientific data indicates that HMOs have unique
health benefits.
Pioneering science
Backed by more than 145 years of innovation and our curiosity
to pioneer, we constantly strive to anticipate global trends. We
put this into action at our major research facilities in Denmark and
19 application and development center worldwide where we work
closely with our customers to bring new exciting products to the
market. We have a broad and relevant culture collection with access
to close to 40,000 microbial strains. This allows for extensive
screening and selection of the best available combinations of
strains. We have the know-how to solve customer needs and help
them deliver unique, safe and high-quality products.
Sustainability in focus
Chr. Hansen has been supplying natural ingredients to the food industry
for more than 145 years. Understanding of and respect for
nature’s scarce resources have always been an integral part of our
DNA, and we published our first sustainability commitment as early
as 1949. Today, sustainability remains at the core of our overall
strategy. In fact more than 80% of our revenue directly supports
UN’s Sustainable Development Goals. In 2019, our efforts within
sustainability were acknowledged when Chr. Hansen was ranked
as the world’s most sustainable company by Corporate Knights.
In 2020 and 2022, Chr. Hansen confirmed its top position by being
appointed as no. 2 in the global ranking by Corporate Knights.
However, the journey is far from over.
/www.chr-hansen.com
/www.chr-hansen.com
link
